2 min read

Pennsylvania Man Sues C.R. Bard Over IVC Filter Defects, Negligence

A Pennsylvania man named Jose O. suffered an injury from a G2IVC (Inferior Vena Cava) Filter and has officially filed suit against the device’s manufacturer, C.R. Bard. The lawsuit states that Bard sold and authorized the use of a defective medical device and neglected to provide sufficient warning about serious risks and side effects.

On May 21, 2006, Jose O. had the IVC Filter surgically implanted in his inferior vena cava to prevent a potential pulmonary embolism (blood clots in the lungs), the main purpose of an IVC Filter. Years later in 2010, Bard recalled the G2Ⓡ IVC Filter from the market and replaced it with a newer model. This new model was also found to have similar defects. Several studies have linked both models to high fracture rates and embolization, revealing that over 12% of G2Ⓡ IVC Filters fractured. Even with this knowledge, C.R. Bard kept their devices on the market until 2010.

After these severe defects were uncovered, further studies were done indicating up to a 40% risk of fracture for the G2Ⓡ Filter, showing increased risk correlating with the length of time that the implant remains in the patient’s vein.

The current lawsuit accuses C.R. Bard of “designing, manufacturing and selling a knowingly defective device, failing to warn of the side effects, negligence, negligent misrepresentation, breach of implied and express warranty, and fraudulent misrepresentation.”

If you’ve received an IVC Filter and have experienced any abnormal symptoms, you could be entitled to financial compensation. Contact the defective medical device attorneys at My Vaccine Lawyer and get your free consultation today. (800)-229-7704.

*The official lawsuit was filed on December 7, 2017 in the U.S. District Court of the District of Arizona. It will be centralized with over 2,000 other IVC filter lawsuits that were previously filed against C.R. Bard in a consolidated federal litigation in Arizona.